Clinical Trials Directory

Trials / Unknown

UnknownNCT05416710

Universal Germline Testing in the Community

Prospective Community Cancer Clinics-based Approach to Optimize Germline Testing in Cancer Patients in Rural Setting to Address Racial Disparities: UNIversal Germline Testing in the communitY (UNITY) Study

Status
Unknown
Phase
Study type
Observational
Enrollment
1,000 (estimated)
Sponsor
Invitae Corporation · Industry
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

This study seeks to enroll participants who have a diagnosis of a solid tumor cancer and are willing to undergo germline genetic testing for cancer risk. At baseline, patients will be asked to provide 2 types of blood samples: 1 tube for clinical genetic testing and 2 tubes for future research use. A tumor sample from a previous resection or biopsy will also be obtained and sent to the sponsor. The clinician will be asked to provide relevant medical history and demographic information to the sponsor in the form of electronic case report forms.

Detailed description

This study seeks to enroll adult participants who have a diagnosis of a solid tumor cancer and are willing to undergo germline genetic testing for cancer risk using Invitae's Multi-Cancer gene panel. At baseline, patients will be asked to provide 2 types of blood samples: 1 tube for clinical genetic testing and 2 tubes for future research use. A tumor sample from a previous resection or biopsy will also be obtained and sent to the sponsor. The participant's clinician will be asked to provide relevant medical history and demographic information to the sponsor in the form of electronic case report forms at 3 timepoints: 1 month following the results of the participants genetic testing, one year post genetic testing, and 2 years post genetic testing.

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTInvitae's 84 gene multi-cancer panel.Invitae's Multi-Cancer panel analyzes 84 genes associated with hereditary cancers across major organ systems.

Timeline

Start date
2022-06-01
Primary completion
2025-06-01
Completion
2025-06-01
First posted
2022-06-13
Last updated
2022-12-07

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT05416710. Inclusion in this directory is not an endorsement.